Generation and Function of NK Cell Memory
NK细胞记忆的产生和功能
基本信息
- 批准号:9319128
- 负责人:
- 金额:$ 83.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-15 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAntigen ReceptorsAntigen-Presenting CellsAntigensB-Cell DevelopmentB-LymphocytesBook ChaptersCXCR6 geneCell CommunicationCell physiologyCellsCollaborationsContact hypersensitivityDendritic CellsDiagnosisFrequenciesFundingFutureGene ProteinsGenerationsGenesGeneticGenetic RecombinationGoalsHaptensHepaticHeritabilityHomingHumanImmune System DiseasesImmune responseImmunologic MemoryImmunologicsImmunologyImmunotherapyInfectionInfluenzaJ segment geneKnockout MiceLearningLegal patentLiverLymphocyteMediatingMemoryModelingMolecularMusNatural Killer CellsPaperPathway interactionsPeripheralPhenotypePopulationPrionsProcessPropertyRAG1 geneRecruitment ActivityRoleSCID MiceSignal TransductionSiteSourceSpecificitySpleenT-LymphocyteTestingTissuesVaccinesViralViral AntigensVirusVirus DiseasesWorkadaptive immune responseadaptive immunityantiviral immunitybasecancer cellchemokine receptoreditorialexhaustionexperiencehuman diseaseinfectious disease treatmentinfluenzavirusinnate immune functionintravital microscopylymph nodesmacrophagemast cellmulti-photonnoveloffspringpathogenpreventreceptorresidenceresponsesample fixationsuccesstraffickingvaccine developmentvirtual
项目摘要
The formation of antigen (Ag)-specific memory is key for the success of vaccines and for immunotherapy of
infections and cancer, but the cells that carry immunological memory are also implicated in numerous human
disease. T and B cells have been considered sole carriers of immunological memory, so efforts to diagnose,
treat or prevent immune diseases have been focused on these lymphocytes. However, there is mounting
evidence that this T and B cell-centric paradigm requires revision: preliminary work has shown that long-lived
memory can also be acquired by a discrete subset of liver-resident natural killer (NK) cells, which arise in
lymph nodes (LNs) upon encounter of Ag presenting dendritic cells (DCs). To date, NK memory has been
documented for four distinct haptens and six viral Ags. The goals of this project are to elucidate
mechanistically this novel NK cell function and to understand its pathophysiological consequences. Two
specific aims will be pursued: Aim 1 will investigate the mechanisms and consequences of memory NK cell
priming in LNs. To this end, we will characterize the 'naive' memory-capable NK cell subset(s) and
investigate the molecular mechanism that provides Ag-specificity; we will analyze the dynamics of NK cell
interactions with DCs In LNs; and we will explore whether human NK cells can also acquire memory. Aim 2
will characterize recall responses of primed NK cells using haptens and influenza virus as models. Here, we
will investigate memory NK cell trafficking at steady state and upon rechallenge; analyze memory NK cell
mediated protection during influenza infection; and explore the role of negative costimulation in memory NK
cell generation, persistence and function.
抗原(AG)特异性记忆的形成是疫苗成功和免疫疗法成功的关键
感染和癌症,但携带免疫记忆的细胞也与许多人有关
疾病。 T和B细胞已被认为是免疫记忆的唯一载体,因此诊断,
治疗或预防免疫疾病已集中在这些淋巴细胞上。但是,有安装
以这种为中心细胞范式需要修订的证据:初步工作表明长寿
记忆也可以通过肝居住的天然杀手(NK)细胞的离散子集获取
淋巴结(LNS)遇到Ag呈现的树突状细胞(DC)。迄今为止,NK内存已经
记录了四种不同的触觉和六个病毒AG。该项目的目标是阐明
从机械上讲,这种新型的NK细胞功能并了解其病理生理后果。二
将追求具体目标:AIM 1将研究记忆NK单元的机制和后果
在LNS中启动。为此,我们将表征“幼稚”可容纳内存的NK单元子集和
研究提供Ag特异性的分子机制;我们将分析NK单元的动力学
与LNS中的DC相互作用;我们将探讨人类NK细胞是否也可以获取记忆。目标2
将使用触觉和流感病毒作为模型来表征启动NK细胞的回忆反应。在这里,我们
将调查记忆NK细胞在稳定状态下和补偿时的贩运;分析记忆NK单元
流感感染期间介导的保护;并探索负面刺激在记忆NK中的作用
细胞产生,持久性和功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ULRICH H VON ANDRIAN其他文献
ULRICH H VON ANDRIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ULRICH H VON ANDRIAN', 18)}}的其他基金
Intravascular Immune Surveillance by Anti-viral T Cells
抗病毒 T 细胞的血管内免疫监视
- 批准号:
10304141 - 财政年份:2020
- 资助金额:
$ 83.48万 - 项目类别:
Intravascular Immune Surveillance by Anti-viral T Cells
抗病毒 T 细胞的血管内免疫监视
- 批准号:
10509385 - 财政年份:2020
- 资助金额:
$ 83.48万 - 项目类别:
Regulation of Skin Inflammation by Nociceptive Sensory Neurons
伤害性感觉神经元对皮肤炎症的调节
- 批准号:
9268505 - 财政年份:2015
- 资助金额:
$ 83.48万 - 项目类别:
Mechanisms and Immunological Consequences of Host-Virus Interactions
宿主-病毒相互作用的机制和免疫学后果
- 批准号:
9110861 - 财政年份:2014
- 资助金额:
$ 83.48万 - 项目类别:
Mechanisms and Immunological Consequences of Host-Virus Interactions
宿主-病毒相互作用的机制和免疫学后果
- 批准号:
9322437 - 财政年份:2014
- 资助金额:
$ 83.48万 - 项目类别:
Mechanisms and Immunological Consequences of Host-Virus Interactions
宿主-病毒相互作用的机制和免疫学后果
- 批准号:
8742510 - 财政年份:2014
- 资助金额:
$ 83.48万 - 项目类别:
相似海外基金
Role of TLR7-mediated B cell activation in primary Sjogren’s syndrome
TLR7 介导的 B 细胞激活在原发性干燥综合征中的作用
- 批准号:
10676443 - 财政年份:2023
- 资助金额:
$ 83.48万 - 项目类别:
HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
HORMAD 特异性 TGF-β 耐药性记忆 T 细胞用于治疗胃食管癌患者
- 批准号:
10731407 - 财政年份:2023
- 资助金额:
$ 83.48万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 83.48万 - 项目类别:
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
利用造血干细胞衍生的初始 CAR T 细胞利用胸腺来长期控制肿瘤
- 批准号:
10365031 - 财政年份:2022
- 资助金额:
$ 83.48万 - 项目类别:
Synthetic IL9R signaling to rewire T cells for adoptive cell therapy of cancer
合成 IL9R 信号传导重新连接 T 细胞用于癌症过继细胞治疗
- 批准号:
10504059 - 财政年份:2022
- 资助金额:
$ 83.48万 - 项目类别: